Want to join the conversation?
$BMY said the company's R&D expenses increased to $1.1Bil in 2Q16, primarily due to grants. The company said it now expects R&D spend to increase in the mid teens range, driven by investments in Opdivo and other immuno-oncology programs. This also relates to the increased spending related to business development transactions completed in FY16.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.